Biotech · Private company · Baltimore, MD, US
Rezigene, LLC
Track this companyFree. Adds Rezigene, LLC to your Dealase workspace and tells you when its record changes.
Clinical trials0None registered
Pipeline programs0None found yet
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
NIH awards2
- Developing an Anti-proteotoxicity Therapy for Neurodegenerative DiseasesFiscal year 2025 · $344.5KNIH RePORTER 5R41NS137860-02 · fetched Nov 12, 2026
- Developing an Anti-proteotoxicity Therapy for Neurodegenerative DiseasesFiscal year 2024 · $349.9KNIH RePORTER 1R41NS137860-01 · fetched Nov 12, 2026